Showing results (2291-2300 of 25,162) with videos related to
Sort By:
Pageof 2,517
Oncotarget|August 25, 2016
IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathwayLeong-Perng Chan, Ling-Feng Wang, Feng-Yu Chiang, et al.Oncotarget|August 27, 2016
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)Marco Perez, Javier Peinado-Serrano, Jose Manuel Garcia-Heredia, et al.Oncotarget|August 27, 2016
Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancerJianchang Qian, Yaqing Chen, Tao Meng, et al.Oncotarget|August 27, 2016
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cellsHoracio Cardenas, Janice Zhao, Edyta Vieth, et al.Oncotarget|August 27, 2016
ATF6α regulates morphological changes associated with senescence in human fibroblastsClémentine Druelle, Claire Drullion, Julie Deslé, et al.Oncotarget|August 27, 2016
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanomaGiuseppina Conteduca, Daniela Fenoglio, Alessia Parodi, et al.Oncotarget|August 27, 2016
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicinePoonam Nagpal, Mohamed R Akl, Nehad M Ayoub, et al.Oncotarget|August 27, 2016
Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancerCheolwon Choi, Junyeob Kwon, Sunyoung Lim, et al.Oncotarget|August 27, 2016
An anti-ErbB2 fully human antibody circumvents trastuzumab resistanceQiong Lu, Lingfei Wang, Yajun Zhang, et al.Oncotarget|August 27, 2016
Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cellsRaghuveer Kavarthapu, Maria L DufauPageof 2,517